Methylome-wide association study of schizophrenia: Identifying blood biomarker signatures of environmental insults

JAMA Psychiatry

Volumn 71, Issue 3, 2014, Pages 255-264

  Aberg, Karolina A ^a   McClay, Joseph L ^a   Nerella, Srilaxmi ^a   Clark, Shaunna ^a   Kumar, Gaurav ^a   Chen, Wenan ^a   Khachane, Amit N ^a   Xie, Linying ^a   Hudson, Alexandra ^a   Gao, Guimin ^a   Harada, Aki ^a   Hultman, Christina M ^b   Sullivan, Patrick F ^b   Magnusson, Patrik K E ^b   Van Den Oord, Edwin J C G ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BISULFITE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; DOPAMINE; E1A ASSOCIATED P300 PROTEIN; FAM63B PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; METHYL CPG BINDING PROTEIN; MICRORNA; RELN PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EPAS1; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROL; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION; GENE REPLICATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HYPOXIA; INFECTION; MAJOR CLINICAL STUDY; MALE; METHYLOME WIDE ASSOCIATION STUDY; NERVE CELL DIFFERENTIATION; PYROSEQUENCING; SCHIZOPHRENIA; SMOKING; SWEDEN; UPREGULATION;

BIOLOGICAL MARKERS; DNA METHYLATION; EPIGENOMICS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; REGISTRIES; SCHIZOPHRENIA; SEQUENCE ANALYSIS, DNA; SWEDEN;

EID: 84896732939     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2013.3730     Document Type: Article

References (73)

1. Mill J, Tang T, Kaminsky Z, et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet. 2008;82(3):696-711.
2. Mill J, Petronis A. Molecular studies of major depressive disorder: the epigenetic perspective. Mol Psychiatry. 2007;12(9):799-814.
3. van Os J, Kapur S. Schizophrenia. Lancet. 2009;374(9690):635-645.
4. Boks MP, de Jong NM, KasMJ, et al. Current status and future prospects for epigenetic psychopharmacology. Epigenetics. 2012;7(1):20-28.
5. Aberg KA, Xie LY, McClay JL, et al. Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions. Epigenomics. 2013;5(4):367-377.
6. Christensen BC, Houseman EA, Marsit CJ, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 2009;5(8): e1000602.
7. Efstratiadis A. Parental imprinting of autosomal mammalian genes. Curr Opin Genet Dev. 1994;4(2):265-280.
8. Sutherland JE, Costa M. Epigenetics and the environment. Ann N Y Acad Sci. 2003;983:151-160.
9. Kerkel K, Spadola A, Yuan E, et al. Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet. 2008;40(7):904-908.
10. Carrard A, Salzmann A, Malafosse A, Karege F. Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. J Affect Disord. 2011;132(3):450-453.
11. Chen Y, Zhang J, Zhang L, Shen Y, Xu Q. Effects of MAOA promoter methylation on susceptibility to paranoid schizophrenia. Hum Genet. 2012;131(7):1081-1087.
12. Dempster EL, Pidsley R, Schalkwyk LC, et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 2011;20(24):4786-4796.
13. Lott SA, Burghardt PR, Burghardt KJ, Bly MJ, Grove TB, Ellingrod VL. The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia. Pharmacogenomics J. 2013;13(3):264-271.
14. Melas PA, Rogdaki M, Ösby U, SchallingM, Lavebratt C, Ekström TJ. Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset. FASEB J. 2012;26(6):2712-2718.
15. Petronis A, Gottesman II, Kan P, et al. Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? Schizophr Bull. 2003;29(1):169-178.
16. Zhang AP, Yu J, Liu JX, et al. The DNA methylation profile within the 5'-regulatory region of DRD2 in discordant sib pairs with schizophrenia. Schizophr Res. 2007;90(1-3):97-103.
17. Scarr E, Craig JM, CairnsMJ, et al. Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targetingmicroRNA. Transl Psychiatry. 2013;3:e230.
18. Abdolmaleky HM, Cheng KH, Faraone SV, et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet. 2006;15(21):3132-3145.
19. Abdolmaleky HM, Cheng KH, Russo A, et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet. 2005;134B(1):60-66.
20. Abdolmaleky HM, Yaqubi S, Papageorgis P, et al. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophr Res. 2011;129(2-3):183-190.
21. Dempster EL, Mill J, Craig IW, Collier DA. The quantification of COMTmRNAin post mortem cerebellum tissue: diagnosis, genotype,methylation and expression. BMC Med Genet. 2006;7:10.
22. Grayson DR, Jia X, Chen Y, et al. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci U S A. 2005;102(26):9341-9346.
23. Iwamoto K, Bundo M, Yamada K, et al. DNA methylation status of SOX10 correlateswith its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci. 2005;25(22):5376-5381.
24. Nohesara S, GhadirivasfiM, Mostafavi S, et al. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J Psychiatr Res. 2011;45(11):1432-1438.
25. Tochigi M, Iwamoto K, Bundo M, et al. Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biol Psychiatry. 2008;63(5):530-533.
26. Tolosa A, Sanjuán J, Dagnall AM, Moltó MD, Herrero N, de Frutos R. FOXP2 gene and language impairment in schizophrenia: association and epigenetic studies. BMC Med Genet. 2010;11:114.
27. Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet. 2011;12(8):529-541.
28. Serre D, Lee BH, Ting AH. MBD-isolated Genome Sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome. Nucleic Acids Res. 2010;38(2):391-399.
29. Aberg KA, McClay JL, Nerella S, et al. MBD-seq as a cost-effective approach for methylome-wide association studies: demonstration in 1500 case-control samples. Epigenomics. 2012;4(6):605-621.
30. ChenW, Gao G, Nerella S, et al.MethylPCA: a toolkit to control for confounders in methylome-wide association studies. BMC Bioinformatics. 2013;14:74.
31. van den Oord EJ, Bukszar J, Rudolf G, et al. Estimation of CpG coverage in wholemethylome next-generation sequencing studies. BMC Bioinformatics. 2013;14(1):50.
32. Bergen SE, O'Dushlaine CT, Ripke S, et al. Genome-wide association study in a Swedish population yields support for greater CNV andMHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry. 2012;17(9):880-886.
33. Bock C, Tomazou EM, Brinkman AB, et al. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol. 2010;28(10):1106-1114.
34. Bollen KA. Structural Equations With Latent Variables. New York, NY: Wiley; 1989.
35. Gower JC. Some distance properties of latent root and vector methods used in multivariate analysis. Biometrika. 1966;53:325-338. doi:10.2307/2333639.
36. Houseman EA, Accomando WP, Koestler DC, et al. DNA methylation arrays as surrogate measures of cellmixture distribution. BMC Bioinformatics. 2012;13:86.
37. Liu Y, AryeeMJ, Padyukov L, et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol. 2013;31(2):142-147.
38. Sun YV, Turner ST, Smith JA, et al. Comparison of the DNA methylation profiles of human peripheral blood cells and transformed B-lymphocytes.Hum Genet. 2010;127(6):651-658.
39. Kamburov A, Pentchev K, Galicka H, Wierling C, Lehrach H, Herwig R. ConsensusPathDB: toward a more complete picture of cell biology. Nucleic Acids Res. 2011;39(Database issue):D712-D717.
40. Pentchev K, Ono K, Herwig R, Ideker T, Kamburov A. Evidence mining and novelty assessment of protein-protein interactions with the ConsensusPathDB plugin for Cytoscape. Bioinformatics. 2010;26(21):2796-2797.
41. Kamburov A, Wierling C, Lehrach H, Herwig R. ConsensusPathDB-a database for integrating human functional interaction networks. Nucleic Acids Res. 2009;37(Database issue):D623-D628.
42. Croft D, O'Kelly G,Wu G, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2011;39(Database issue):D691-D697.
43. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012;40(Database issue):D109-D114.
44. Tost J, Dunker J, Gut IG. Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing. Biotechniques. 2003;35(1):152-156.
45. Aparicio A, North B, Barske L, et al. LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors. Epigenetics. 2009;4(3):176-184.
46. Storey JD. The positive false discovery rate: a Bayesian interpretation and the q-value. Ann Stat. 2003;31(6):2013-2035. doi:10.1214/aos /1074290335.
47. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100(16):9440-9445.
48. Elvert G, Kappel A, Heidenreich R, et al. Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem. 2003;278(9):7520-7530.
49. Tan XL, Zhai Y, Gao WX, et al. p300 expression is induced by oxygen deficiency and protects neuron cells from damage. Brain Res. 2009;1254:1-9.
50. Hu CJ,Wang LY, Chodosh LA, Keith B, Simon MC. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol. 2003;23(24):9361-9374.
51. Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 2002;16(10):1151-1162.
52. Xue Y, Li NL, Yang JY, Chen Y, Yang LL, LiuWC. Phosphatidylinositol 3'-kinase signaling pathway is essential for Rac1-induced hypoxia-inducible factor-1(alpha) and vascular endothelial growth factor expression. Am J Physiol Heart Circ Physiol. 2011;300(6):H2169-H2176.
53. Beckman JD, Chen C, Nguyen J, et al. Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217. J Biol Chem. 2011;286(5):3194-3202.
54. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. Expression profiling of mammalianmicroRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004;5(3):R13.
55. Huang T, Liu Y, HuangM, Zhao X, Cheng L. Wnt1-cre-mediated conditional loss of Dicer results in malformation of the midbrain and cerebellum and failure of neural crest and dopaminergic differentiation inmice. J Mol Cell Biol. 2010;2(3):152-163.
56. HuangW, LiMD. Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. Biol Psychiatry. 2009;65(8):702-705.
57. Guidotti A, Auta J, Davis JM, et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study [published correction appears in Arch Gen Psychiatry. 2002;59(1):12]. Arch Gen Psychiatry. 2000;57(11):1061-1069.
58. Impagnatiello F, Guidotti AR, Pesold C, et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A. 1998;95(26):15718-15723.
59. Dong E, Agis-Balboa RC, Simonini MV, Grayson DR, Costa E, Guidotti A. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc Natl Acad Sci U S A. 2005;102(35):12578-12583.
60. Tamura Y, Kunugi H, Ohashi J, Hohjoh H. Epigenetic aberration of the human REELIN gene in psychiatric disorders. Mol Psychiatry. 2007;12(6):593-600.
61. Sørensen LT, Jørgensen S, Petersen LJ, et al. Acute effects of nicotine and smoking on blood flow, tissue oxygen, and aerobe metabolism of the skin and subcutis. J Surg Res. 2009;152(2):224-230.
62. Guo L, Li L,WangW, Pan Z, Zhou Q,Wu Z. Mitochondrial reactive oxygen species mediates nicotine-induced hypoxia-inducible factor-1a expression in human non-small cell lung cancer cells. Biochim Biophys Acta. 2012;1822(6):852-861.
63. Schmidt-Kastner R, van Os J, Steinbusch HWM, Schmitz C. Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia. Schizophr Res. 2006;84(2-3):253-271.
64. Ralph GS, Parham S, Lee SR, et al. Identification of potential stroke targets by lentiviral vector mediated overexpression of HIF-1 alpha and HIF-2 alpha in a primary neuronal model of hypoxia. J Cereb Blood Flow Metab. 2004;24(2):245-258.
65. Murgatroyd C, Patchev AV,Wu Y, et al. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci. 2009;12(12):1559-1566.
66. Nestler EJ. Epigenetics: stress makes its molecular mark. Nature. 2012;490(7419):171-172.
67. Sullivan PF, DalyMJ, O'DonovanM. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet. 2012;13(8):537-551.
68. Schilling E, El Chartouni C, RehliM. Allele-specific DNA methylation in mouse strains is mainly determined by cis-acting sequences. Genome Res. 2009;19(11):2028-2035.
69. Zhang Y, Rohde C, Reinhardt R, Voelcker-Rehage C, Jeltsch A. Non-imprinted allele-specific DNA methylation on human autosomes. Genome Biol. 2009;10(12):R138.
70. Schalkwyk LC, Meaburn EL, Smith R, et al. Allelic skewing of DNA methylation is widespread across the genome. Am J Hum Genet. 2010;86(2):196-212.
71. Kennedy JL, Farrer LA, Andreasen NC, Mayeux R, St George-Hyslop P. The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science. 2003;302(5646):822-826.
72. Herr KJ, Herr DR, Lee CW, Noguchi K, Chun J. Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling. Proc Natl Acad Sci U S A. 2011;108(37):15444-15449.
73. Chavez L, Jozefczuk J, Grimm C, et al. Computational analysis of genome-wide DNA methylation during the differentiation of human embryonic stem cells along the endodermal lineage. Genome Res. 2010;20(10):1441-1450.